1. Home
  2. PTGX vs BOOT Comparison

PTGX vs BOOT Comparison

Compare PTGX & BOOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • BOOT
  • Stock Information
  • Founded
  • PTGX 2006
  • BOOT 1978
  • Country
  • PTGX United States
  • BOOT United States
  • Employees
  • PTGX N/A
  • BOOT N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • BOOT Clothing/Shoe/Accessory Stores
  • Sector
  • PTGX Health Care
  • BOOT Consumer Discretionary
  • Exchange
  • PTGX Nasdaq
  • BOOT Nasdaq
  • Market Cap
  • PTGX 2.9B
  • BOOT 3.3B
  • IPO Year
  • PTGX 2016
  • BOOT 2014
  • Fundamental
  • Price
  • PTGX $53.34
  • BOOT $164.30
  • Analyst Decision
  • PTGX Strong Buy
  • BOOT Strong Buy
  • Analyst Count
  • PTGX 9
  • BOOT 12
  • Target Price
  • PTGX $67.11
  • BOOT $176.17
  • AVG Volume (30 Days)
  • PTGX 898.5K
  • BOOT 638.9K
  • Earning Date
  • PTGX 08-05-2025
  • BOOT 08-06-2025
  • Dividend Yield
  • PTGX N/A
  • BOOT N/A
  • EPS Growth
  • PTGX N/A
  • BOOT 22.50
  • EPS
  • PTGX 0.86
  • BOOT 5.88
  • Revenue
  • PTGX $207,801,000.00
  • BOOT $1,911,104,000.00
  • Revenue This Year
  • PTGX N/A
  • BOOT $14.33
  • Revenue Next Year
  • PTGX $47.15
  • BOOT $12.95
  • P/E Ratio
  • PTGX $62.27
  • BOOT $27.98
  • Revenue Growth
  • PTGX N/A
  • BOOT 14.64
  • 52 Week Low
  • PTGX $30.67
  • BOOT $86.17
  • 52 Week High
  • PTGX $60.60
  • BOOT $176.64
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 58.33
  • BOOT 62.11
  • Support Level
  • PTGX $54.48
  • BOOT $156.05
  • Resistance Level
  • PTGX $57.18
  • BOOT $165.05
  • Average True Range (ATR)
  • PTGX 2.04
  • BOOT 4.77
  • MACD
  • PTGX -0.09
  • BOOT -1.84
  • Stochastic Oscillator
  • PTGX 57.13
  • BOOT 62.19

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About BOOT Boot Barn Holdings Inc.

Boot Barn Holdings Inc operates specialty retail stores. The company sells western and work-related footwear, apparel, and accessories in the United States. It is a single operating segment, which includes net sales generated from its retail stores and e-commerce websites.

Share on Social Networks: